NEW YORK (Reuters Health) – According to a new report, primary care patients who may have a drug use disorder can be reliably identified with a single-question screening…
NEW YORK (Reuters Health) – Children and adolescents with juvenile idiopathic arthritis who have a clinical response to treatment with the biologic agent abatacept experience a significant improvement…
NEW YORK (Reuters Health) – First-line therapy with zidovudine and interferon-alpha improves overall survival in patients with adult T-cell leukemia/lymphoma (ATL), according to the results of a retrospective…
NEW YORK (Reuters Health) – Patients with chronic heart failure have a higher mortality risk or are more likely to undergo a heart transplant if they have low…
NEW YORK (Reuters Health) – During the first year of treatment for chronic hepatitis B, tenofovir and entecavir are the most effective antiviral agents available, according to the…
NEW YORK (Reuters Health) –There’s no reliable evidence to support or refute the use of glucocorticoids for treating anaphylaxis, despite recommendations found in several guidelines, according to the…
NEW YORK (Reuters Health) – Early, prehospital administration of nebulized 5% saline to infants with acute bronchiolitis reduces illness severity significantly without undue side effects, according to the…
NEW YORK (Reuters Health) – The dose of misoprostol given after mifepristone for termination of early pregnancy should stay at the recommended dose rather than be lowered, a…
Andre Machado, MD, Director, Center for Neurological Research, Cleveland Clinic, discusses deep brain stimulation, a technique that uses implantable pacemakers in the brain for treating neurological and psychiatric…
Michael Swiernik, MD, Director, Medical Informatics, UCLA, discusses “meaningful use” and the criteria for definition that are not yet defined. There are several key areas that need to…
